logo
Select company
Select metric
6005.32%Stock Based Compensation Margin
VS
Market
1
Sector
2
Industry
5
History
13
$ 41.57Close
$ 25.56 - $ 60.69 52-Week Range
Ticker Information

Ticker

CRNX

Company Name

CRINETICS PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CRINETICS PHARMACEUTICALS INC - Stock Based Compensation Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRNX - SB Comp % Historical data
DateRevenuesStock Based CompensationStock Based Compensation Margin
6/30/2025$ 1.39M$ 83.59M6005.32%
3/31/2025$ 760K$ 76.41M10053.95%
12/31/2024$ 1.04M$ 69.39M6678.15%
9/30/2024$ 1.04M$ 62.16M5982.48%
6/30/2024$ 1.39M$ 55.06M3975.45%
3/31/2024$ 1.97M$ 46.3M2345.24%
12/31/2023$ 4.01M$ 40.94M1020.11%
9/30/2023$ 4.72M$ 37.27M789.24%
6/30/2023$ 4.83M$ 33.65M696.17%
3/31/2023$ 4.29M$ 30.61M714.33%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CRINETICS PHARMACEUTICALS INC's latest trailing twelve months (TTM) SB Comp % stands at 2369.13%.
  • Over the past 5 years, CRINETICS PHARMACEUTICALS INC's average SB Comp % has been 3469.13%.
  • The median SB Comp % for CRINETICS PHARMACEUTICALS INC during this period was 1609.65%
  • CRINETICS PHARMACEUTICALS INC reached its highest SB Comp % over the past 5 years at 14685.92%.
  • The lowest SB Comp % recorded by CRINETICS PHARMACEUTICALS INC in the same timeframe 468.07%

CRINETICS PHARMACEUTICALS INC's SB Comp % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

SB Comp % Benchmarks
CompanySB Comp %
KALV : KALVISTA PHARMACEUTICALS INC 1025.95%INBX : INHIBRX BIOSCIENCES INC 797.64%CGON : CG ONCOLOGY INC 3592.92%IMVT : IMMUNOVANT INC -CLSD : CLEARSIDE BIOMEDICAL INC 278.72%PLUR : PLURI INC 160.4%IGC : IGC PHARMA INC 127.35%OTLK : OUTLOOK THERAPEUTICS INC 563.54%ONCO : ONCONETIX INC 33.69%SPRB : SPRUCE BIOSCIENCES INC 197.69%

Definition of Stock Based Compensation Margin

[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for CRINETICS PHARMACEUTICALS INC is calculated as follows: SB Comp. [ $ 9.29M ] / Revenues [ $ 392K ]
(=) SB Comp % [ 2369.13% ]

CRNX - Stock Based Compensation Margin, Last 5 years

468.07%

Minimum

Mar 31, 2022

14685.92%

Maximum

Dec 31, 2020

3469.13%

Average

1609.65%

Median

SB Comp % Benchmark Analysis

The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
filtered constituents2.99K
min-3.97%
max8.43%
average1.72%
median1.04%
std1.9%